Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 16 July 2027
- Last conf. stmt
- 2 July 2026
Transpharmation Ltd.
- Incorporated
- 17 August 2010 (16 years)
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Aly Khan ChampsiJoseph Araujo
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- The London Bioscience Innovation Centre2 Royal College StreetLondonNW1 0NH
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Champsi, Aly Khan
Director · Appointed 30 July 2024
Canadian
Born February 1980 (46)
Araujo, Joseph
Director · Appointed 16 September 2021
Canadian
Born December 1974 (51)
British
Born April 1972 (54)
Officer history (4 former)
30 July 2024
Appointed Champsi, Aly Khan as Director
3 December 2021
Resigned Lawrence, Karen Melissa as Director
3 December 2021
Resigned Upton, Susan as Director
3 December 2021
16 September 2021
Appointed Araujo, Joseph as Director
17 October 2016
Appointed Lawrence, Karen Melissa as Director
17 October 2016
Appointed Upton, Susan as Director
23 January 2012
23 January 2012
Resigned Lawrence, Karen Melissa as Director
17 August 2010
Appointed Lawrence, Karen Melissa as Director
17 August 2010
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 1
Companies where Transpharmation Ltd. is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (3)
30 July 2024
Ceased Joseph Araujo — Owns 25–50% of shares
3 December 2021
1 December 2021
Ceased Vivocore Inc. — Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £4,477,364
- Cash
- £616,195
- Employees
- 28
- Current Ratio
- 5.1x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £5,223 | £21,358 | £94,167 | £92,439 | £46,457 |
| Current Assets | £5,574,434 | £7,711,207 | £2,831,318 | £3,337,777 | £2,329,868 |
| Debtors | £4,958,239 | £3,364,728 | £1,805,462 | £1,984,028 | £1,911,594 |
| Cash | £616,195 | £4,346,479 | £1,025,856 | £1,353,749 | £418,274 |
| Creditors (< 1 year) | £1,102,293 | £1,153,495 | £575,249 | £518,359 | £240,071 |
| Net Current Assets | £4,472,141 | £6,557,712 | £2,256,069 | £2,819,418 | £2,089,797 |
| Net Assets | £4,477,364 | £6,579,070 | £2,350,236 | £2,911,857 | £2,136,254 |
| Shareholder Funds | £4,477,364 | £6,579,070 | £2,350,236 | £2,911,857 | £2,136,254 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 August 2026 | Confirmation statement with no updates | 2 July 2026 | ||
| 1 October 2025 | Director's details changed | |||
| 30 September 2025 | Total exemption full accounts | 31 December 2024 | ||
| 31 July 2025 | Confirmation statement with updates | 2 July 2025 | ||
| 26 August 2024 | Registration of a charge |
Some other companies at this address
Other companies in this industry
Cambridge
Normanton
Hessle
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →